ZSFab, Inc. appears in FDA device records as an applicant for cervical interbody fusion devices rather than as a broad-platform manufacturer. The company's documented product is the ZSAlign Cervical Interbody System, filed under regulation 21 CFR 888.3080 and product codes OVE and ODP. Two 510(k) records carry the ZSFab name in the material reviewed here: K261451, received and dated July 10, 2026, and K263113, received September 4, 2026. Both are recorded with a substantially equivalent decision. The filings describe a Class II orthopedic device; they do not establish sales, clinical outcomes or commercial availability. [1][3][9]

The ZSAlign Cervical Interbody System as filed

The ZSAlign Cervical Interbody System is identified in FDA records as an intervertebral fusion device with integrated fixation, cervical, classified under product code OVE and regulation number 888.3080 in Class II. The K261451 cover letter lists product codes OVE and ODP for the same trade name. FDA's device classification entry places the product in the orthopedic medical specialty, and the advisory committee for K263113 is recorded as orthopedic. These records describe the device category and review pathway; they do not disclose materials, dimensions or surgical technique. [1][3][9]

Two dated 510(k) submissions

K261451 was received July 10, 2026, and FDA's decision letter is dated July 31, 2026, addressed to ZSFab, Inc. care of a regulatory specialist at ATS in Colorado Springs. The K261451 record shows a traditional 510(k), not reviewed by a third party, with a summary available and no predetermined change control plan authorized. K263113 was received September 4, 2026, and decided October 2, 2026, with a clearance type recorded as special and a summary available. The K263113 record lists the applicant address as 96 Clematis Ave., Suite 2f, Waltham, MA, and names David Ma as contact. [1][3][7][9]

The K261451 decision letter states that non-clinical testing results show the strength of the ZSAlign Cervical Interbody System is sufficient for its intended use and substantially equivalent to legally marketed predicate devices. That conclusion rests on mechanical performance and technology characteristics as described in the letter. No clinical study results, outcome rates or patient-selection criteria appear in the reviewed records. [3]

Establishment registration and listing

FDA establishment registration and device listing records return one result for registration number 3022943642, listed as ZSFAB INC, MA/USA, with a current registration year of 2026. The listing text references an intervertebral fusion device with bone graft, cervical, under the ZSFab name. The registration number also appears among registration numbers in the K263113 openFDA fields. Registration and listing confirm an establishment record; they do not indicate manufacturing volume, facility capabilities or distribution. [4][6][1]

What the record set does and does not show

The linked collection contains one 510(k) record, K263113, with a single substantially equivalent decision in the decision counts; the record sample is the same single entry. A separate K261451 record appears in the numbered FDA sources and is described above on its own terms. Neither count should be read as total company filings, total portfolio or safety performance. No recall records appear in the linked collection. Ownership, parent companies, brand relationships, headquarters, website and customers are not established by these records; the Waltham address is a filing address, not a verified headquarters. [1][3][4][9]